glp-1 and dpp-4 inhibitors The Role of GLP-1, DPP-4, SGLT-2 in Diabetes Management Design principles of long-acting DPP-4

Within minutes, it reaches therapeutic concentrations in your blood a level that oral supplements may take days or weeks to approach, if at all

4 MERCS as a structural signaling platform to GLP-1 receptor Contemporary understanding of the GLP-1R has transitioned from a model of linear, diffuse signaling at the plasma membrane to a sophisticated architecture of spatiotemporally organized nanodomains known as signalosomes ( 2+ flux, lipid transport, and bioenergetic restoration

Podocytes derived from human induced pluripotent stem cells: characterization, comparison, and modeling of diabetic kidney disease

Dual-driven nanomotors enable tumor penetration and hypoxia alleviation for calcium overload-photo-immunotherapy against colorectal cancer